- Home
- AIRI vs CLDI Comparison
AIRI vs CLDI Comparison
Compare AIRI & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- CLDI
- Stock Information
- Founded
- AIRI 1979
- CLDI 2014
- Country
- AIRI United States
- CLDI United States
- Employees
- AIRI N/A
- CLDI N/A
- Industry
- AIRI Military/Government/Technical
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIRI Industrials
- CLDI Health Care
- Exchange
- AIRI Nasdaq
- CLDI Nasdaq
- Market Cap
- AIRI 15.4M
- CLDI 18.1M
- IPO Year
- AIRI N/A
- CLDI N/A
- Fundamental
- Price
- AIRI $4.35
- CLDI $1.47
- Analyst Decision
- AIRI
- CLDI Strong Buy
- Analyst Count
- AIRI 0
- CLDI 3
- Target Price
- AIRI N/A
- CLDI $16.67
- AVG Volume (30 Days)
- AIRI 45.8K
- CLDI 1.2M
- Earning Date
- AIRI 11-14-2024
- CLDI 11-12-2024
- Dividend Yield
- AIRI N/A
- CLDI N/A
- EPS Growth
- AIRI N/A
- CLDI N/A
- EPS
- AIRI N/A
- CLDI N/A
- Revenue
- AIRI $53,657,000.00
- CLDI N/A
- Revenue This Year
- AIRI $9.26
- CLDI N/A
- Revenue Next Year
- AIRI $8.73
- CLDI N/A
- P/E Ratio
- AIRI N/A
- CLDI N/A
- Revenue Growth
- AIRI 3.31
- CLDI N/A
- 52 Week Low
- AIRI $3.00
- CLDI $0.73
- 52 Week High
- AIRI $9.44
- CLDI $18.50
- Technical
- Relative Strength Index (RSI)
- AIRI 38.83
- CLDI 37.87
- Support Level
- AIRI $4.11
- CLDI $1.60
- Resistance Level
- AIRI $4.60
- CLDI $2.17
- Average True Range (ATR)
- AIRI 0.26
- CLDI 0.20
- MACD
- AIRI 0.02
- CLDI -0.08
- Stochastic Oscillator
- AIRI 30.77
- CLDI 5.37
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.